Mirum Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 264
- Market Cap
- $2.1B
- Website
- http://www.mirumpharma.com
- Introduction
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Phase 3
Completed
- Conditions
- Zellweger SyndromeCholestasisInfantile Refsum's DiseaseAdrenoleukodystrophyPeroxisomal Disorders
- Interventions
- Drug: Cholic Acids
- First Posted Date
- 2000-12-07
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Mirum Pharmaceuticals, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT00007020
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath